During the past decade, NSABP Operations Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NSABP Operations Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "International Drug Development Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "NSABP Operations Center" are "Breast Neoplasms" (2 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "NSABP Operations Center" in a lesser frequency.

Most popular intervention types in "NSABP Operations Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Irinotecan" (1 trials), "Nanoparticle albumin bound paclitaxel followed by FEC" (1 trials) and "Oxaliplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "NSABP Operations Center" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "NSABP Operations Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NSABP Operations Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NSABP Operations Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".